Published in Immunol Rev on December 01, 2001
Techniques for assessing knee joint pain in arthritis. Mol Pain (2007) 1.38
Generating gene knockout rats by homologous recombination in embryonic stem cells. Nat Protoc (2011) 1.32
Key regulatory molecules of cartilage destruction in rheumatoid arthritis: an in vitro study. Arthritis Res Ther (2008) 1.28
Cigarette smoking and risk of rheumatoid arthritis: a dose-response meta-analysis. Arthritis Res Ther (2014) 1.19
Association between occupational exposure to mineral oil and rheumatoid arthritis: results from the Swedish EIRA case-control study. Arthritis Res Ther (2005) 1.14
Cartilage preservation by inhibition of Janus kinase 3 in two rodent models of rheumatoid arthritis. Arthritis Res Ther (2008) 1.10
Lessons from animal models of arthritis over the past decade. Arthritis Res Ther (2009) 1.10
Anti-inflammatory effect of antidiabetic thiazolidinediones prevents bone resorption rather than cartilage changes in experimental polyarthritis. Arthritis Res Ther (2008) 1.05
Animal models used to examine the role of the environment in the development of autoimmune disease: findings from an NIEHS Expert Panel Workshop. J Autoimmun (2012) 1.05
Differential gene expression in pristane-induced arthritis susceptible DA versus resistant E3 rats. Arthritis Res Ther (2003) 0.98
Beyond knockout rats: new insights into finer genome manipulation in rats. Cell Cycle (2011) 0.96
Gait changes precede overt arthritis and strongly correlate with symptoms and histopathological events in pristane-induced arthritis. Arthritis Res Ther (2010) 0.96
Expert panel workshop consensus statement on the role of the environment in the development of autoimmune disease. Int J Mol Sci (2014) 0.91
Integrated gene expression profiling and linkage analysis in the rat. Mamm Genome (2006) 0.90
The role and clinical implications of G6PI in experimental models of rheumatoid arthritis. Arthritis Res Ther (2004) 0.90
Quantitative dynamic models of arthritis progression in the rat. Pharm Res (2008) 0.89
Infections in hemodialysis: a concise review - Part 1: bacteremia and respiratory infections. Hippokratia (2011) 0.88
Conditional pharmacology/toxicology V: ambivalent effects of thiocyanate upon the development and the inhibition of experimental arthritis in rats by aurothiomalate (Myocrysin®) and metallic silver. Inflammopharmacology (2013) 0.88
BALB/c mice genetically susceptible to proteoglycan-induced arthritis and spondylitis show colony-dependent differences in disease penetrance. Arthritis Res Ther (2009) 0.86
Bb2Bb3 regulation of murine Lyme arthritis is distinct from Ncf1 and independent of the phagocyte nicotinamide adenine dinucleotide phosphate oxidase. Am J Pathol (2005) 0.83
The arthritogenic adjuvant squalene does not accumulate in joints, but gives rise to pathogenic cells in both draining and non-draining lymph nodes. Clin Exp Immunol (2002) 0.82
Gait analysis in rats with single joint inflammation: influence of experimental factors. PLoS One (2012) 0.81
Pharmacokinetics of dexamethasone in a rat model of rheumatoid arthritis. Biopharm Drug Dispos (2008) 0.80
In the rat, citrullinated autologous fibrinogen is immunogenic but the induced autoimmune response is not arthritogenic. Clin Exp Immunol (2006) 0.80
Extra-articular cartilage affected in collagen-induced, but not pristane-induced, arthritis models. Clin Exp Immunol (2002) 0.80
Modeling pharmacokinetics/pharmacodynamics of abatacept and disease progression in collagen-induced arthritic rats: a population approach. J Pharmacokinet Pharmacodyn (2013) 0.80
Relapsing polychondritis, induced in mice with matrilin 1, is an antibody- and complement-dependent disease. Am J Pathol (2004) 0.79
DA rats from two colonies differ genetically and in their arthritis susceptibility. Mamm Genome (2008) 0.79
Rheumatoid arthritis vaccine therapies: perspectives and lessons from therapeutic ligand epitope antigen presentation system vaccines for models of rheumatoid arthritis. Expert Rev Vaccines (2015) 0.79
Anti-arthritic effects of FasL gene transferred intra-articularly by an inducible lentiviral vector containing improved tet-on system. Rheumatol Int (2011) 0.78
Acid-mediated reactions under microfluidic conditions: a new strategy for practical synthesis of biofunctional natural products. Beilstein J Org Chem (2009) 0.78
Adjuvant oil induces waves of arthritogenic lymph node cells prior to arthritis onset. Clin Exp Immunol (2004) 0.78
Effects of soy diet on inflammation-induced primary and secondary hyperalgesia in rat. Eur J Pain (2010) 0.77
Housekeeping gene stability in pristane-induced arthritis and antigen-induced pulmonary inflammation of rats. Inflamm Res (2009) 0.76
Effect of Disease-Related Changes in Plasma Albumin on the Pharmacokinetics of Naproxen in Male and Female Arthritic Rats. Drug Metab Dispos (2017) 0.76
Sensory and vascular changes in a rat monoarthritis model: prophylactic and therapeutic effects of meloxicam. Inflamm Res (2010) 0.76
Phytol-derived novel isoprenoid immunostimulants. Front Immunol (2012) 0.76
VAV1 regulates experimental autoimmune arthritis and is associated with anti-CCP negative rheumatoid arthritis. Genes Immun (2017) 0.75
Decreased expression levels of Ifi genes is associated to the increased resistance to spontaneous arthritis disease in mice deficiency of IL-1RA. BMC Immunol (2016) 0.75
Mineral Oil Aspiration Related Juvenile Idiopathic Arthritis. Case Rep Pulmonol (2015) 0.75
Effects by periodontitis on pristane-induced arthritis in rats. J Transl Med (2016) 0.75
Modeling Sex Differences in Pharmacokinetics, Pharmacodynamics, and Disease Progression Effects of Naproxen in Rats with Collagen-Induced Arthritis. Drug Metab Dispos (2017) 0.75
Gene expression profiling as a tool for positional cloning of genes-shortcut or the longest way round. Curr Genomics (2008) 0.75
Long-Term Effects of (-)-Epigallocatechin Gallate (EGCG) on Pristane-Induced Arthritis (PIA) in Female Dark Agouti Rats. PLoS One (2016) 0.75
Inhibition of the Inositol Kinase Itpkb Augments Calcium Signaling in Lymphocytes and Reveals a Novel Strategy to Treat Autoimmune Disease. PLoS One (2015) 0.75
Cocoa Diet and Antibody Immune Response in Preclinical Studies. Front Nutr (2017) 0.75
[Pain measurement in animal models]. Z Rheumatol (2013) 0.75
Amount of viral DNA in the genome of cells transformed by adenovirus type 2. J Mol Biol (1973) 8.28
Cleavage of adenovirus type 2 DNA into six unique fragments by endonuclease R-RI. Proc Natl Acad Sci U S A (1973) 7.75
Structure of two spliced mRNAs from the transforming region of human subgroup C adenoviruses. Nature (1979) 6.60
The gene for polypeptide IX of adenovirus type 2 and its unspliced messenger RNA. Cell (1980) 5.80
Severe psoriasis--oral therapy with a new retinoid. Dermatologica (1978) 5.67
Virus-receptor interaction in an adenovirus system. J Virol (1968) 4.69
Viral DNA in transformed cells. I. A study of the sequences of adenovirus 2 DNA in a line of transformed rat cells using specific fragments of the viral genome. J Mol Biol (1974) 4.30
Cleavage maps of DNA from adenovirus types 2 and 5 by restriction endonucleases EcoRI and HpaI. Cold Spring Harb Symp Quant Biol (1975) 3.87
Messenger RNAs from the transforming region of bovine papilloma virus type I. J Mol Biol (1985) 3.73
A deletion in the PHYD gene of the Arabidopsis Wassilewskija ecotype defines a role for phytochrome D in red/far-red light sensing. Plant Cell (1997) 3.66
DNA hypomethylation leads to elevated mutation rates. Nature (1998) 3.60
Structure of genes for virus-associated RNAI and RNAII of adenovirus type 2. Proc Natl Acad Sci U S A (1980) 3.45
A forespore checkpoint for mother cell gene expression during development in B. subtilis. Cell (1990) 3.28
Structural proteins of adenoviruses. X. Isolation and topography of low molecular weight antigens from the virion of adenovirus type 2. Virology (1973) 3.26
Proto-oncogene PML controls genes devoted to MHC class I antigen presentation. Nature (1998) 3.22
Cytokine production at the site of disease in human tuberculosis. Infect Immun (1993) 3.04
Cytokine production induced by Mycobacterium tuberculosis lipoarabinomannan. Relationship to chemical structure. J Immunol (1992) 3.03
A new species of virus-coded low molecular weight RNA from cells infected with adenovirus type 2. Cell (1976) 3.00
Targeting of adenovirus E1A and E4-ORF3 proteins to nuclear matrix-associated PML bodies. J Cell Biol (1995) 2.93
Genome of coxsackievirus B3. Virology (1987) 2.88
RNA synthesis and processing in adenovirus-infected cells. Cold Spring Harb Symp Quant Biol (1975) 2.82
Neutralizing antibody-independent containment of immunodeficiency virus challenges by DNA priming and recombinant pox virus booster immunizations. Nat Med (1999) 2.77
Cardiotocography only versus cardiotocography plus ST analysis of fetal electrocardiogram for intrapartum fetal monitoring: a Swedish randomised controlled trial. Lancet (2001) 2.68
Structural proteins of adenoviruses. IV. Sequential degradation of the adenovirus type 2 virion. Virology (1970) 2.65
Viral DNA sequences in cells transformed by simian virus 40, adenovirus type 2 and adenovirus type 5. Cold Spring Harb Symp Quant Biol (1975) 2.65
Hybridization maps of early and late messenger RNA sequences on the adenovirus type 2 genome. J Mol Biol (1976) 2.58
Relationship of mRNA from productively infected cells to the complementary strands of adenovirus type 2 DNA. J Virol (1974) 2.52
Detection of enteroviruses by spot hybridization. J Clin Microbiol (1984) 2.51
Structure of two adenovirus type 12 transforming polypeptides and their evolutionary implications. Nature (1980) 2.38
Structural proteins of adenoviruses. I. Purification and characterization of the adenovirus type 2 hexon antigen. Virology (1967) 2.25
Recombinant Mycobacterium tuberculosis protein associated with mammalian cell entry. Cell Microbiol (2001) 2.12
Synthesis of a structural adenovirus polypeptide in the absence of viral DNA replication. Virology (1978) 2.09
Plasma very long chain fatty acids in 3,000 peroxisome disease patients and 29,000 controls. Ann Neurol (1999) 2.06
Human U2 and U1 RNA genes use similar transcription signals. EMBO J (1984) 2.01
A common sequence in the inverted terminal repetitions of human and avian adenoviruses. Gene (1982) 2.00
High-risk behaviors during incarceration in African-American men treated for HIV at three Los Angeles public medical centers. J Acquir Immune Defic Syndr (2000) 2.00
A deletion in the amelogenin gene (AMG) causes X-linked amelogenesis imperfecta (AIH1). Genomics (1991) 1.99
Interleukin 12 at the site of disease in tuberculosis. J Clin Invest (1994) 1.98
Rapid and quantitative recovery of DNA fragments from gels by displacement electrophoresis (isotachophoresis). Biochim Biophys Acta (1984) 1.97
Capture PCR: efficient amplification of DNA fragments adjacent to a known sequence in human and YAC DNA. PCR Methods Appl (1991) 1.96
Analysis of clinical specimens by hybridisation with probe containing repetitive DNA from Plasmodium falciparum. A novel approach to malaria diagnosis. Lancet (1984) 1.92
mRNAs from human adenovirus 2 early region 4. J Virol (1984) 1.92
Structure and function of virion proteins of adenoviruses. Prog Exp Tumor Res (1973) 1.91
Multiple Trypanosoma cruzi antigens containing tandemly repeated amino acid sequence motifs. Mol Biochem Parasitol (1988) 1.91
Survival in patients with abdominal aortic aneurysms. Comparison between operative and nonoperative management. Eur J Vasc Surg (1990) 1.90
A distant enhancer element is required for polymerase III transcription of a U6 RNA gene. Nature (1987) 1.89
Identification of a Trypanosoma cruzi antigen that is shed during the acute phase of Chagas' disease. Mol Biochem Parasitol (1989) 1.88
Complementary strand-specific sequences from unique fragments of adenovirus type 2 DNA for hybridization-mapping experiments. J Mol Biol (1974) 1.83
Splicing of adenovirus 2 early region 1A mRNAs is non-sequential. J Mol Biol (1983) 1.82
Location of sequences on the adenovirus genome coding for the 5.5S RNA. Cell (1975) 1.81
TWISTing stemness, inflammation and proliferation of epithelial ovarian cancer cells through MIR199A2/214. Oncogene (2010) 1.81
A putative vulnerability locus to multiple sclerosis maps to 5p14-p12 in a region syntenic to the murine locus Eae2. Nat Genet (1996) 1.81
Sequence analysis of adenovirus DNA: complete nucleotide sequence of the spliced 5' noncoding region of adenovirus 2 hexon messenger RNA. Cell (1979) 1.73
Patterns of cytokine production by mycobacterium-reactive human T-cell clones. Infect Immun (1993) 1.72
Synthesis of complementary RNA sequences during productive adenovirus infection. Proc Natl Acad Sci U S A (1974) 1.70
Viral DNA sequences and gene products in hamster cells transformed by adenovirus type 2. J Virol (1978) 1.69
Delayed umbilical cord clamping at birth has effects on arterial and venous blood gases and lactate concentrations. BJOG (2008) 1.69
Sequences of bovine papillomavirus type 1 DNA--functional and evolutionary implications. Nucleic Acids Res (1983) 1.68
Sequence analysis of adenovirus DNA. I. Nucleotide sequence at the carboxy-terminal end of the gene for adenovirus type 2 hexon. Virology (1978) 1.66
An inducible human immunodeficiency virus type 1 (HIV-1) vector which effectively suppresses HIV-1 replication. J Virol (1999) 1.61
Structural proteins of adenoviruses. II. Purification and characterization of the adenovirus type 2 fiber antigen. Virology (1968) 1.60
Clustered genes for human U2 RNA. Proc Natl Acad Sci U S A (1984) 1.59
Structural proteins of adenoviruses. VII. Purification and properties of an arginine-rich core protein from adenovirus type 2 and type 3. Virology (1971) 1.59
Genetic identification of an endoproteinase encoded by the adenovirus genome. J Mol Biol (1983) 1.58
Cooperative interactions between transcription factors Sp1 and OTF-1. Proc Natl Acad Sci U S A (1990) 1.57
Marking and gene expression by a lentivirus vector in transplanted human and nonhuman primate CD34(+) cells. J Virol (2000) 1.55
Familial persistent hyperinsulinemic hypoglycemia of infancy and mutations in the sulfonylurea receptor. N Engl J Med (1997) 1.55
The low molecular weight of RNAs of adenovirus 2-infected cells. J Mol Biol (1978) 1.54
[Cloning and identification of cDNA fragments related to human esophageal cancer]. Zhonghua Zhong Liu Za Zhi (1998) 1.51
YakA, a protein kinase required for the transition from growth to development in Dictyostelium. Development (1998) 1.51
Effects of intraaortic balloon pumping on septal arterial blood flow velocity waveform during severe left main coronary artery stenosis. J Am Coll Cardiol (1996) 1.51
Substance use and risky sexual behavior in female adolescents. Drug Alcohol Depend (1997) 1.50
Montelukast added to inhaled beclomethasone in treatment of asthma. Montelukast/Beclomethasone Additivity Group. Am J Respir Crit Care Med (1999) 1.50
Two complementary strand-specific termination sites for adenovirus DNA replication. Cell (1976) 1.50
A schizophrenia-susceptibility locus at 6q25, in one of the world's largest reported pedigrees. Am J Hum Genet (2001) 1.49
Dynamic organization of splicing factors in adenovirus-infected cells. J Virol (1995) 1.48
Transcriptional activation of the human papillomavirus-16 P97 promoter by an 88-nucleotide enhancer containing distinct cell-dependent and AP-1-responsive modules. New Biol (1990) 1.47
Adenovirus 3 fiber polypeptide gene: implications for the structure of the fiber protein. J Virol (1985) 1.47
The renal medulla and hypertension. Hypertension (1995) 1.46
The molecular structure of the 9S mRNA from early region 1A of adenovirus serotype 2. J Mol Biol (1983) 1.46
Nucleotide sequence at the junction between the coding region of the adenovirus 2 hexon messenger RNA and its leader sequence. Proc Natl Acad Sci U S A (1978) 1.45
Adenovirus endonuclease: association with the penton of adenovirus type 2. J Mol Biol (1971) 1.45
DNA sequence analysis of the region encoding the terminal protein and the hypothetical N-gene product of adenovirus type 2. J Biol Chem (1982) 1.44
Internal basic proteins in adenovirus. Virology (1968) 1.43
Immunocalins: a lipocalin subfamily that modulates immune and inflammatory responses. Biochim Biophys Acta (2000) 1.41
Studies of the neutralizing activity and avidity of anti-human immunodeficiency virus type 1 Env antibody elicited by DNA priming and protein boosting. J Virol (1998) 1.39
Chronically KIT-stimulated clonally-derived human mast cells show heterogeneity in different tissue microenvironments. J Invest Dermatol (1997) 1.39
Region E3 of human adenoviruses; differences between the oncogenic adenovirus-3 and the non-oncogenic adenovirus-2. Gene (1986) 1.39
Specific fragmentation of DNA of adenovirus serotypes 3, 5, 7, and 12, and adeno-simian virus 40 hybrid virus Ad2+ND1 by restriction endonuclease R.EcoRI. J Virol (1974) 1.39
The presence of beta-receptors in the submaxillary gland of the dog. Br J Pharmacol Chemother (1967) 1.37
Inversion of the IDS gene resulting from recombination with IDS-related sequences is a common cause of the Hunter syndrome. Hum Mol Genet (1995) 1.37
Association between hyperactivity and executive cognitive functioning in childhood and substance use in early adolescence. J Am Acad Child Adolesc Psychiatry (1999) 1.36
Erlotinib as second-line treatment in patients with advanced non-small-cell lung cancer and asymptomatic brain metastases: a phase II study (CTONG-0803). Ann Oncol (2012) 1.36
The gene and messenger RNA for adenovirus polypeptide IX. Cell (1977) 1.34
Sructural proteins of adenoviruses. 3. Purification and characterization of the adenovirus type 2 penton antigen. Virology (1969) 1.34
Identification of proteins interacting with the enhancer of human U2 small nuclear RNA genes. Nucleic Acids Res (1987) 1.32
Promoters and processing sites within the transforming region of bovine papillomavirus type 1. J Virol (1987) 1.32